These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16379014)

  • 1. Left main coronary artery disease: is CABG still the gold standard?
    Ng MK; Yeung AC
    Rev Cardiovasc Med; 2005; 6(4):187-93. PubMed ID: 16379014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention for unprotected left main coronary artery stenosis.
    Park SJ; Kim YH
    Cardiol Clin; 2010 Feb; 28(1):81-95. PubMed ID: 19962051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.
    Tanigawa J; Sutaria N; Goktekin O; Di Mario C
    J Interv Cardiol; 2005 Dec; 18(6):455-65. PubMed ID: 16336426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?
    Park SJ; Park DW
    Circ Cardiovasc Interv; 2009 Feb; 2(1):59-68. PubMed ID: 20031694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting.
    Mäkikallio TH; Niemelä M; Kervinen K; Jokinen V; Laukkanen J; Ylitalo I; Tulppo MP; Juvonen J; Huikuri HV
    Ann Med; 2008; 40(6):437-43. PubMed ID: 18608116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
    Hordijk-Trion M; Lenzen M; Wijns W; de Jaegere P; Simoons ML; Scholte op Reimer WJ; Bertrand ME; Mercado N; Boersma E;
    Eur Heart J; 2006 Mar; 27(6):671-8. PubMed ID: 16423872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
    Ong AT; Serruys PW; Mohr FW; Morice MC; Kappetein AP; Holmes DR; Mack MJ; van den Brand M; Morel MA; van Es GA; Kleijne J; Koglin J; Russell ME
    Am Heart J; 2006 Jun; 151(6):1194-204. PubMed ID: 16781219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is stenting a preferred option for unprotected left main coronary artery disease in the drug-eluting stent era?
    Park SJ
    Indian Heart J; 2007; 59(2 Suppl B):B105-12. PubMed ID: 19153426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
    Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and intermediate-term results of percutaneus left main coronary artery interventions.
    Teplitsky I; Asali A; Vaknin H; Golovchiner G; Fuchs S; Battler A; Kornowski R
    Isr Med Assoc J; 2004 Oct; 6(10):579-82. PubMed ID: 15473581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H; Kawai N; Umemoto T
    Am J Cardiol; 2008 May; 101(9):1259-62. PubMed ID: 18435954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry).
    Palmerini T; Marzocchi A; Marrozzini C; Ortolani P; Saia F; Savini C; Bacchi-Reggiani L; Gianstefani S; Virzì S; Manara F; Kiros Weldeab M; Marinelli G; Di Bartolomeo R; Branzi A
    Am J Cardiol; 2006 Jul; 98(1):54-9. PubMed ID: 16784920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients.
    Brener SJ; Galla JM; Bryant R; Sabik JF; Ellis SG
    Am J Cardiol; 2008 Jan; 101(2):169-72. PubMed ID: 18178401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery.
    Jaffery Z; Kowalski M; Weaver WD; Khanal S
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):691-7. PubMed ID: 17300948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience.
    Chieffo A; Morici N; Maisano F; Bonizzoni E; Cosgrave J; Montorfano M; Airoldi F; Carlino M; Michev I; Melzi G; Sangiorgi G; Alfieri O; Colombo A
    Circulation; 2006 May; 113(21):2542-7. PubMed ID: 16717151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.